The contract manufacturing sector is being shaped by many factors, including a focus on innovative therapies and the need to offer even greater value to pharmaceutical companies. CDMOs such as Recipharm are responding by investing in new technologies, adding capacity and building in new markets. Contract service providers that offer a comprehensive range of services and global reach are in high demand as they help to simplify the supply chain, while also fulfilling the quality level expectations of multiple markets.
Our executive vice president and head of strategy and global integration at Recipharm, Jean-Francois Hilaire, joined a group of industry executives to discuss the changing dynamics within the CDMO landscape in Contract Pharma.
Read the full article here:
Changing Dynamics: The CDMO market in focus